0001209191-22-053411.txt : 20221012
0001209191-22-053411.hdr.sgml : 20221012
20221012081156
ACCESSION NUMBER: 0001209191-22-053411
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221007
FILED AS OF DATE: 20221012
DATE AS OF CHANGE: 20221012
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kwan Rudolf
CENTRAL INDEX KEY: 0001708965
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38112
FILM NUMBER: 221305600
MAIL ADDRESS:
STREET 1: C/O ATHENEX, INC. 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athenex, Inc.
CENTRAL INDEX KEY: 0001300699
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 431985966
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
BUSINESS PHONE: 716-898-8625
MAIL ADDRESS:
STREET 1: 1001 MAIN STREET
STREET 2: SUITE 600
CITY: BUFFALO
STATE: NY
ZIP: 14203
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals, Inc.
DATE OF NAME CHANGE: 20131223
FORMER COMPANY:
FORMER CONFORMED NAME: Kinex Pharmaceuticals LLC
DATE OF NAME CHANGE: 20040817
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-10-07
0
0001300699
Athenex, Inc.
ATNX
0001708965
Kwan Rudolf
C/O ATHENEX, INC.,
1001 MAIN STREET, SUITE 600
BUFFALO
NY
14203
0
1
0
0
EVP, Chief Medical Officer
Common Stock
2022-10-07
4
A
0
20340
0.2409
A
362064
D
Stock Option (Right to Buy)
4.55
2016-01-02
2023-01-02
Common Stock
96000
96000
D
Stock Option (Right to Buy)
4.55
2018-05-13
2023-05-13
Common Stock
48000
48000
D
Stock Option (Right to Buy)
4.55
2018-02-12
2024-02-12
Common Stock
120000
120000
D
Stock Option (Right to Buy)
4.55
2017-06-12
2024-06-12
Common Stock
48000
48000
D
Stock Option (Right to Buy)
5.50
2018-12-16
2024-12-16
Common Stock
200000
200000
D
Stock Option (Right to Buy)
7.50
2019-05-22
2025-05-22
Common Stock
120000
120000
D
Stock Option (Right to Buy)
11.00
2020-06-13
2027-06-13
Common Stock
140000
140000
D
Stock Option (Right to Buy)
17.30
2022-03-27
2028-03-27
Common Stock
120000
120000
D
Stock Option (Right to Buy)
13.17
2029-02-28
Common Stock
120000
120000
D
Stock Option (Right to Buy)
12.45
2030-06-05
Common Stock
140000
140000
D
Stock Option (Right to Buy)
3.80
2031-08-03
Common Stock
70000
70000
D
Restricted Stock Units
Common Stock
52500
52500
D
Stock Option (Right to Buy)
0.6655
2032-07-20
Common Stock
75000
75000
D
Shares purchased from the Issuer under a Salary Deduction and Stock Purchase Agreement at the Nasdaq Official Closing Price on the date of purchase.
This option vests in four equal annual installments beginning on February 28, 2020.
This option vests in four equal annual installments beginning on June 5, 2021.
The option vests in four equal annual installments beginning on August 3, 2022.
Each restricted stock unit represents a contingent right to receive one share of stock.
The restricted stock units vest in four equal annual installments beginning on August 3, 2022.
This option vests in four equal annual installments beginning on July 20, 2023.
/s/ Steven Adams, Attorney-in-Fact
2022-10-12